Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 8/20 | 0.47 |
| ▸ | CA12 | O43570 | 7/20 | 0.47 |
| ▸ | CA1 | P00915 | 7/20 | 0.47 |
| ▸ | CA2 | P00918 | 7/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.44 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NEK2 | P51955 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6394050 | 1.00 | JAK3 (0.48) | JAK3CA9CA12CA1CA2 | |
| SCHEMBL4152157 | 0.82 | TP53 (0.43) | JAK3MAPTMEN1KMT2ACACNA1B | |
| SCHEMBL4152156 | 0.82 | TP53 (0.43) | JAK3MAPTMEN1KMT2ACACNA1B | |
| SCHEMBL4009452 | 0.74 | POLB (0.55) | CA9CA12CA1CA2CA14 | |
| SCHEMBL11860070 | 0.73 | CA9 (0.56) | CA9CA12CA1CA2CA14 | |
| SCHEMBL4144063 | 0.70 | NEK2 (0.49) | JAK3POLBMAPTMEN1KMT2A | |
| SCHEMBL4144065 | 0.70 | NEK2 (0.49) | JAK3POLBMAPTMEN1KMT2A | |
| SCHEMBL11560494 | 0.70 | PPME1 (0.55) | POLBMAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4572353 | 0.70 | NFKB1 (0.58) | CA9CA12CA1CA2CA14 | |
| SCHEMBL11560496 | 0.70 | PPME1 (0.55) | POLBMAPTMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1484051-B1 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | OREAL (FR) | 2013-08-21 | — | — | EP | disclosed |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | L'OREAL (FR) | 2009-03-19 | — | — | US | disclosed |
| US-20050008588-A1 | Aminoarylvinyl-s-triazine compounds and uses thereof | L'OREAL (FR) | 2005-01-13 | — | — | US | disclosed |
| EP-1484051-A2 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | L'OREAL (FR) | 2004-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050008588-A1 | Aminoarylvinyl-s-triazine compounds and uses thereof | TYR, AAAS, ALAD | JAK3 339/4885CA9 4631/4885CA12 4086/4885 |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | TYR, AAAS, ALAD | JAK3 276/4885CA9 4631/4885CA12 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.